Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Sachiko Yamamoto-Kataoka"'
Autor:
Hiromitsu Kaneko, Akiko Hanamoto, Sachiko Yamamoto-Kataoka, Yuki Kataoka, Takuya Aoki, Kokoro Shirai, Hiroyasu Iso
Publikováno v:
International journal of environmental research and public health. 19(23)
Various tools to measure patient complexity have been developed. Primary care physicians often deal with patient complexity. However, their usefulness in primary care settings is unclear. This study explored complexity measurement tools in general ad
Autor:
Yasukazu Hijikata, Sachiko Yamamoto-Kataoka, Sayaka Shimizu, Shunichi Fukuhara, Yosuke Yamamoto
Publikováno v:
Annals of Clinical Epidemiology. 2:113-120
Autor:
Sachiko Yamamoto Kataoka, Yosuke Yamamoto, Kentaro Tochitani, Yuki Kataoka, Chisato Miyakoshi
Publikováno v:
Pediatrics International
Background To combat the coronavirus disease 2019 pandemic, many countries, including Japan, implemented policies limiting social activities and encouraging preventive behaviors. This study examines the influence of such policies on the trends of 10
Autor:
Yasushi Tsujimoto, Sachiko Yamamoto-Kataoka, Yuki Kataoka, Hajime Yamazaki, Toshi A. Furukawa, Shunsuke Taito
BackgroundThe background section of a medical journal article has the important function to communicate readers the value of the research question. However, little is known about how authors describe their “niche” to emphasize the importance of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::418fe46eae48b1cb252b2613bf2a7659
https://doi.org/10.1101/2020.01.19.20018127
https://doi.org/10.1101/2020.01.19.20018127
Autor:
Sachiko Yamamoto Kataoka, Norio Watanabe, Kana Inoue, Sumihiro Kawano, Toshi A. Furukawa, Noemi Lois
Publikováno v:
Cochrane Database Syst Rev
Inoue, K, Kataoka, S Y, Kawano, S, Furukawa, T A, Lois, N & Watanabe, N 2019, ' Fenofibrate for diabetic retinopathy ', Cochrane Database of Systematic Reviews, vol. 2019, no. 4, CD013318 . https://doi.org/10.1002/14651858.CD013318
Inoue, K, Kataoka, S Y, Kawano, S, Furukawa, T A, Lois, N & Watanabe, N 2019, ' Fenofibrate for diabetic retinopathy ', Cochrane Database of Systematic Reviews, vol. 2019, no. 4, CD013318 . https://doi.org/10.1002/14651858.CD013318
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To investigate the effects of fenofibrate on the prevention and progression of diabetic retinopathy.
Autor:
Nobuya Inagaki, Yosuke Yamamoto, Sachiko Yamamoto-Kataoka, Katsuhiro Murakami, Sayaka Shimizu, Daisuke Nishizaki, Shunichi Fukuhara, Hajime Yamazaki
Publikováno v:
Medicine. 100:e26311
Pancreatectomy is an invasive surgery that is sometimes associated with complications. New-onset diabetes mellitus sometimes develops after partial pancreatectomy and severely affects the patient's quality of life. This study aimed to develop a preop
Autor:
Yasushi Tsujimoto, Yuki Kataoka, Hajime Yamazaki, Sachiko Yamamoto-Kataoka, Toshi A. Furukawa, Shunsuke Taito
Publikováno v:
Medicine. 99:e23801
Objectives To clarify the styles used in background sections of systematic reviews (SR) and to identify which styles if any were related to the publication in high-impact-factor (HIF) medical journals. Method This was a cross-sectional study for orig
Autor:
Sachiko Yamamoto-Kataoka, Sayaka Shimizu, Hajime Yamazaki, Katsuhiro Murakami, Daisuke Nishizaki, Shunichi Fukuhara, Nobuya Inagaki, Yosuke Yamamoto, Yamamoto-Kataoka, Sachiko, Shimizu, Sayaka, Yamazaki, Hajime, Murakami, Katsuhiro, Nishizaki, Daisuke, Fukuhara, Shunichi, Inagaki, Nobuya, Yamamoto, Yosuke
Publikováno v:
Medicine; 6/18/2021, Vol. 100 Issue 24, p1-7, 7p
Autor:
Megumi Aizawa-Abe, Sachiko Yamamoto-Kataoka, Mingming Zhao, Daisuke Aotani, Kazuwa Nakao, Miki Nishio, Kiminori Hosoda, Akira Suzuki, Chihiro Ebihara, Takeru Sakai, Yuji Yamamoto, Toru Kusakabe, Valentino Gumbilai, Ken Ebihara
Publikováno v:
Hormone and Metabolic Research. 47:168-175
Nonalcoholic fatty liver disease (NAFLD) is recognized as the hepatic component of the metabolic syndrome. Although NAFLD is a major cause of cirrhosis and cancer of the liver of unknown cause, no established pharmacological treatment for NAFLD has b
Autor:
Kazuwa Nakao, Michio Noguchi, Junji Fujikura, Takeru Sakai, Mingming Zhao, Chihiro Ebihara, Yuji Yamamoto, Toru Kusakabe, Sachiko Yamamoto-Kataoka, Kiminori Hosoda, Nobuya Inagaki, Daisuke Aotani, Valentino Gumbilai, Megumi Aizawa-Abe, Ken Ebihara
Publikováno v:
American Journal of Physiology-Endocrinology and Metabolism. 307:E712-E719
Leptin may reduce pancreatic lipid deposition, which increases with progression of obesity and can impair β-cell function. The insulinotropic effect of glucagon-like peptide-1 (GLP-1) and the efficacy of GLP-1 receptor agonist are reduced associated